摘要
急性心力衰竭(AHF)是心脏慢性疾病的急性发作,其发病率、死亡率均较高,严重影响患者的生活质量,增加经济负担。本文主要综述AHF治疗药物研究进展以及射血分数降低心力衰竭(HFr EF)的药物治疗,以期为临床治疗提供新的依据。
Acute heart failure（AHF） is an acute attack of chronic heart disease, which has high morbidity and mortality, the quality of life is seriously affected and the economic burden of patients is increased. This review summarizes the research progress of AHF therapeutic drugs and treatment drugs for HFr EF, in order to provide a new basis for clinical
作者
郑刚
ZHENG Gang(Department of Cardiology, Tianjin Third Central Hospital Branch, Tianjin 300250, Chin)
出处
《世界临床药物》
CAS
2018年第4期276-279,共4页
World Clinical Drug
